| P2093 | author name string | Hong Yu | |
| | Ai-Gui Jiang | |
| | Jian-An Huang | |
| P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
| | Global cancer statistics | Q22241238 |
| | Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway | Q28207963 |
| | Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 |
| | Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 |
| | Ras, PI(3)K and mTOR signalling controls tumour cell growth | Q29614734 |
| | Exploiting the PI3K/AKT pathway for cancer drug discovery | Q29615120 |
| | Phosphoinositide 3-kinase signalling pathways | Q33940898 |
| | Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells | Q34480703 |
| | Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway | Q34887795 |
| | Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance | Q36092560 |
| | Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine | Q36358107 |
| | DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation | Q39830099 |
| | Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. | Q40333129 |
| | Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors | Q40343282 |
| | Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies | Q40574083 |
| | Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. | Q44156173 |
| | Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions | Q44968631 |
| | Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer | Q46443619 |
| | Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity | Q46606786 |
| | Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis | Q47680928 |
| | The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. | Q53229977 |
| | Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer. | Q54713896 |
| | Receptor tyrosine kinases and inhibitors in lung cancer. | Q55387993 |
| | Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage | Q80901395 |
| P433 | issue | 2 | |
| P921 | main subject | lung carcinoma | Q18556110 |
| P304 | page(s) | 601-607 | |
| P577 | publication date | 2014-05-22 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma | |
| P478 | volume | 8 | |